 Kurt Beam
Concepts (345)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium Channels, L-Type | 58 | 2022 | 117 | 8.580 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 38 | 2023 | 72 | 6.200 |
Why?
| | Calcium | 58 | 2023 | 1190 | 3.940 |
Why?
| | Calcium Channels | 48 | 2012 | 157 | 3.850 |
Why?
| | Muscle Fibers, Skeletal | 27 | 2022 | 212 | 3.410 |
Why?
| | Muscle, Skeletal | 45 | 2023 | 1789 | 3.030 |
Why?
| | Calcium Signaling | 18 | 2021 | 245 | 2.870 |
Why?
| | Ion Channel Gating | 18 | 2015 | 94 | 2.730 |
Why?
| | Muscle Contraction | 35 | 2012 | 429 | 2.370 |
Why?
| | Muscles | 38 | 2008 | 330 | 1.970 |
Why?
| | Excitation Contraction Coupling | 8 | 2022 | 13 | 1.700 |
Why?
| | Nerve Tissue Proteins | 5 | 2018 | 591 | 1.560 |
Why?
| | Calcium Channels, N-Type | 2 | 2025 | 12 | 1.560 |
Why?
| | Muscle Proteins | 15 | 2017 | 242 | 1.470 |
Why?
| | Muscular Diseases | 11 | 2016 | 108 | 1.280 |
Why?
| | Malignant Hyperthermia | 6 | 2023 | 8 | 1.200 |
Why?
| | Cell Membrane | 11 | 2025 | 707 | 1.150 |
Why?
| | Membrane Proteins | 3 | 2025 | 1164 | 1.080 |
Why?
| | Membrane Potentials | 23 | 2013 | 278 | 1.060 |
Why?
| | Neurons | 8 | 2021 | 1649 | 1.030 |
Why?
| | Cells, Cultured | 39 | 2018 | 4148 | 0.950 |
Why?
| | Animals | 114 | 2025 | 38030 | 0.910 |
Why?
| | Mice | 77 | 2023 | 18329 | 0.910 |
Why?
| | Luminescent Proteins | 10 | 2012 | 186 | 0.900 |
Why?
| | Animals, Newborn | 20 | 2018 | 891 | 0.850 |
Why?
| | Endoplasmic Reticulum | 2 | 2025 | 264 | 0.750 |
Why?
| | Mutation | 13 | 2023 | 4075 | 0.740 |
Why?
| | Electrophysiology | 24 | 2012 | 218 | 0.700 |
Why?
| | Action Potentials | 16 | 2022 | 502 | 0.700 |
Why?
| | Sarcoplasmic Reticulum | 13 | 2017 | 40 | 0.690 |
Why?
| | Recombinant Fusion Proteins | 12 | 2016 | 666 | 0.650 |
Why?
| | Mutation, Missense | 3 | 2013 | 335 | 0.650 |
Why?
| | Caveolin 1 | 3 | 2017 | 20 | 0.640 |
Why?
| | Motor Neurons | 9 | 1999 | 236 | 0.620 |
Why?
| | Rabbits | 19 | 2018 | 652 | 0.580 |
Why?
| | Cell Line | 10 | 2021 | 2823 | 0.530 |
Why?
| | Ion Channels | 9 | 1988 | 129 | 0.500 |
Why?
| | Myocardium | 11 | 2012 | 934 | 0.500 |
Why?
| | Mice, Mutant Strains | 17 | 2012 | 302 | 0.480 |
Why?
| | HEK293 Cells | 3 | 2025 | 741 | 0.470 |
Why?
| | Mutant Proteins | 1 | 2016 | 105 | 0.460 |
Why?
| | Amino Acid Sequence | 16 | 2015 | 2129 | 0.460 |
Why?
| | DNA, Complementary | 15 | 2012 | 273 | 0.450 |
Why?
| | Protein Binding | 9 | 2025 | 2238 | 0.440 |
Why?
| | Calcium Channel Blockers | 11 | 2009 | 166 | 0.430 |
Why?
| | Molecular Sequence Data | 15 | 2015 | 2883 | 0.400 |
Why?
| | Kinetics | 15 | 2016 | 1567 | 0.400 |
Why?
| | Myoblasts, Skeletal | 2 | 2010 | 12 | 0.400 |
Why?
| | Heart | 5 | 2001 | 626 | 0.390 |
Why?
| | Neuromuscular Junction | 5 | 2009 | 65 | 0.380 |
Why?
| | Dihydropyridines | 9 | 2003 | 15 | 0.380 |
Why?
| | Protein Subunits | 6 | 2016 | 229 | 0.370 |
Why?
| | Ryanodine | 3 | 2009 | 15 | 0.370 |
Why?
| | 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 7 | 2013 | 11 | 0.360 |
Why?
| | Receptors, Nicotinic | 10 | 1991 | 327 | 0.350 |
Why?
| | Adaptor Proteins, Signal Transducing | 4 | 2022 | 425 | 0.330 |
Why?
| | Patch-Clamp Techniques | 9 | 2010 | 289 | 0.330 |
Why?
| | Muscle, Striated | 1 | 2010 | 12 | 0.320 |
Why?
| | Purkinje Cells | 3 | 1999 | 65 | 0.310 |
Why?
| | Sodium Channels | 3 | 1999 | 63 | 0.310 |
Why?
| | Protein Structure, Tertiary | 6 | 2015 | 855 | 0.300 |
Why?
| | Microtubules | 4 | 1999 | 265 | 0.290 |
Why?
| | Binding Sites | 6 | 2018 | 1310 | 0.290 |
Why?
| | Myofibrils | 1 | 2009 | 49 | 0.290 |
Why?
| | Calcium Channel Agonists | 4 | 2013 | 12 | 0.280 |
Why?
| | Synaptic Transmission | 4 | 2009 | 292 | 0.280 |
Why?
| | Protein Conformation | 9 | 2010 | 938 | 0.270 |
Why?
| | Monomeric GTP-Binding Proteins | 1 | 2008 | 15 | 0.270 |
Why?
| | Transfection | 7 | 2012 | 926 | 0.270 |
Why?
| | Streptavidin | 1 | 2007 | 15 | 0.260 |
Why?
| | Spinal Cord | 3 | 1999 | 382 | 0.240 |
Why?
| | Structure-Activity Relationship | 7 | 2010 | 563 | 0.230 |
Why?
| | Green Fluorescent Proteins | 6 | 2005 | 407 | 0.230 |
Why?
| | Protein Structure, Secondary | 6 | 2012 | 371 | 0.230 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2025 | 18 | 0.220 |
Why?
| | omega-Conotoxins | 2 | 1996 | 4 | 0.220 |
Why?
| | Electric Conductivity | 11 | 2001 | 85 | 0.210 |
Why?
| | Protein Isoforms | 2 | 2021 | 397 | 0.210 |
Why?
| | Potassium | 5 | 2006 | 152 | 0.200 |
Why?
| | Models, Biological | 8 | 2010 | 1764 | 0.200 |
Why?
| | Halothane | 1 | 2023 | 8 | 0.200 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2023 | 10 | 0.200 |
Why?
| | Fluorescent Dyes | 3 | 2001 | 333 | 0.200 |
Why?
| | Rats | 14 | 2018 | 5584 | 0.190 |
Why?
| | Protein Domains | 1 | 2025 | 311 | 0.190 |
Why?
| | Recombinant Proteins | 5 | 2014 | 1368 | 0.190 |
Why?
| | Sequence Homology, Amino Acid | 6 | 2008 | 387 | 0.190 |
Why?
| | Myocardial Contraction | 3 | 2012 | 293 | 0.190 |
Why?
| | Heat-Shock Response | 1 | 2023 | 77 | 0.180 |
Why?
| | Sinoatrial Node | 1 | 2022 | 27 | 0.180 |
Why?
| | Fluorescence Resonance Energy Transfer | 3 | 2012 | 179 | 0.180 |
Why?
| | Microscopy, Confocal | 4 | 2005 | 319 | 0.180 |
Why?
| | Sodium | 5 | 2011 | 198 | 0.180 |
Why?
| | Signal Transduction | 9 | 2017 | 5216 | 0.170 |
Why?
| | Fluoresceins | 1 | 2001 | 48 | 0.170 |
Why?
| | Cytoplasm | 3 | 2012 | 254 | 0.170 |
Why?
| | Cysteine | 2 | 2005 | 211 | 0.170 |
Why?
| | Calcium Channels, T-Type | 1 | 2003 | 104 | 0.170 |
Why?
| | Organometallic Compounds | 1 | 2001 | 113 | 0.160 |
Why?
| | Mice, Knockout | 4 | 2016 | 3124 | 0.160 |
Why?
| | Bacterial Proteins | 4 | 2012 | 967 | 0.160 |
Why?
| | Lambert-Eaton Myasthenic Syndrome | 2 | 1996 | 3 | 0.150 |
Why?
| | Cerebellum | 2 | 2018 | 224 | 0.150 |
Why?
| | Humans | 21 | 2025 | 145474 | 0.150 |
Why?
| | Caffeine | 6 | 2012 | 74 | 0.150 |
Why?
| | Receptor Cross-Talk | 1 | 1999 | 21 | 0.150 |
Why?
| | Manganese | 2 | 2009 | 55 | 0.140 |
Why?
| | Biotinylation | 2 | 2012 | 37 | 0.140 |
Why?
| | Mice, Neurologic Mutants | 1 | 1998 | 21 | 0.140 |
Why?
| | Prosencephalon | 1 | 2018 | 54 | 0.140 |
Why?
| | Electric Stimulation | 8 | 2004 | 276 | 0.140 |
Why?
| | Blood Proteins | 1 | 2000 | 239 | 0.130 |
Why?
| | Mice, Transgenic | 4 | 2012 | 2188 | 0.130 |
Why?
| | Myocytes, Cardiac | 1 | 2022 | 546 | 0.130 |
Why?
| | Mutagenesis, Site-Directed | 4 | 2005 | 376 | 0.130 |
Why?
| | Ions | 2 | 2008 | 66 | 0.130 |
Why?
| | Chimera | 2 | 1996 | 61 | 0.120 |
Why?
| | Gene Expression Regulation | 3 | 2016 | 2597 | 0.120 |
Why?
| | Nervous System Diseases | 1 | 2000 | 286 | 0.120 |
Why?
| | Alternative Splicing | 1 | 1999 | 247 | 0.120 |
Why?
| | Subcellular Fractions | 1 | 2016 | 73 | 0.120 |
Why?
| | Infant, Extremely Premature | 1 | 2017 | 68 | 0.120 |
Why?
| | Electrophysiological Phenomena | 1 | 2016 | 59 | 0.120 |
Why?
| | Polymerase Chain Reaction | 3 | 2004 | 1041 | 0.110 |
Why?
| | Proteins | 1 | 2001 | 1023 | 0.110 |
Why?
| | Calmodulin | 2 | 2008 | 70 | 0.110 |
Why?
| | Oxadiazoles | 2 | 1992 | 37 | 0.110 |
Why?
| | Fluorescence | 2 | 2012 | 159 | 0.110 |
Why?
| | DNA | 7 | 1993 | 1435 | 0.110 |
Why?
| | Receptors, Purinergic P1 | 1 | 1994 | 30 | 0.110 |
Why?
| | Motor Endplate | 3 | 1986 | 15 | 0.100 |
Why?
| | Developmental Disabilities | 1 | 2017 | 281 | 0.100 |
Why?
| | Bone and Bones | 1 | 1996 | 317 | 0.100 |
Why?
| | Plasmids | 6 | 1994 | 373 | 0.100 |
Why?
| | Cell Fusion | 2 | 1990 | 48 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 1 | 2018 | 2524 | 0.090 |
Why?
| | Triclosan | 1 | 2012 | 9 | 0.090 |
Why?
| | Hippocampus | 1 | 2018 | 971 | 0.090 |
Why?
| | Adenosine | 1 | 1994 | 255 | 0.090 |
Why?
| | Molecular Docking Simulation | 1 | 2012 | 119 | 0.090 |
Why?
| | Anti-Infective Agents, Local | 1 | 2012 | 40 | 0.090 |
Why?
| | Barium | 4 | 1998 | 27 | 0.090 |
Why?
| | Biotin | 1 | 2012 | 32 | 0.090 |
Why?
| | Cloning, Molecular | 3 | 2001 | 538 | 0.090 |
Why?
| | Time Factors | 6 | 2010 | 7123 | 0.090 |
Why?
| | Sarcomeres | 2 | 2009 | 97 | 0.080 |
Why?
| | Amino Acid Substitution | 2 | 2002 | 302 | 0.080 |
Why?
| | Fibroblasts | 3 | 1990 | 1025 | 0.080 |
Why?
| | Muscle Development | 4 | 1993 | 112 | 0.070 |
Why?
| | Dantrolene | 1 | 2009 | 5 | 0.070 |
Why?
| | Oligopeptides | 2 | 2001 | 267 | 0.070 |
Why?
| | Nifedipine | 1 | 2009 | 27 | 0.070 |
Why?
| | Hindlimb | 1 | 1989 | 132 | 0.070 |
Why?
| | Point Mutation | 2 | 2001 | 240 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2930 | 0.070 |
Why?
| | Night Blindness | 1 | 2008 | 6 | 0.070 |
Why?
| | Muscular Dystrophies | 1 | 1988 | 28 | 0.070 |
Why?
| | Neuromuscular Diseases | 1 | 1990 | 145 | 0.070 |
Why?
| | Ataxia | 1 | 2008 | 69 | 0.070 |
Why?
| | In Vitro Techniques | 3 | 1997 | 1048 | 0.070 |
Why?
| | Embryo, Nonmammalian | 1 | 1988 | 171 | 0.070 |
Why?
| | Cytosol | 1 | 2008 | 213 | 0.070 |
Why?
| | Embryo, Mammalian | 1 | 1988 | 234 | 0.060 |
Why?
| | Heterozygote | 1 | 2008 | 313 | 0.060 |
Why?
| | Protein Interaction Mapping | 1 | 2007 | 105 | 0.060 |
Why?
| | Biophysical Phenomena | 2 | 1997 | 67 | 0.060 |
Why?
| | Mutagenesis | 2 | 2001 | 194 | 0.060 |
Why?
| | Biophysics | 2 | 1997 | 75 | 0.060 |
Why?
| | Receptors, Cholinergic | 4 | 1990 | 41 | 0.060 |
Why?
| | Genes, Lethal | 1 | 1986 | 30 | 0.060 |
Why?
| | Temperature | 3 | 1985 | 633 | 0.060 |
Why?
| | Chick Embryo | 3 | 1991 | 132 | 0.060 |
Why?
| | Taste | 1 | 1988 | 238 | 0.060 |
Why?
| | Analysis of Variance | 2 | 2012 | 1300 | 0.060 |
Why?
| | Mice, Inbred C57BL | 3 | 2012 | 5983 | 0.060 |
Why?
| | Xanthenes | 2 | 1994 | 10 | 0.050 |
Why?
| | Reference Values | 2 | 1996 | 798 | 0.050 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 1997 | 117 | 0.050 |
Why?
| | Ganglia, Spinal | 2 | 1996 | 88 | 0.050 |
Why?
| | Age Factors | 3 | 2012 | 3342 | 0.050 |
Why?
| | Rats, Inbred Strains | 4 | 1985 | 321 | 0.050 |
Why?
| | Aniline Compounds | 2 | 1994 | 120 | 0.050 |
Why?
| | Potassium Channels | 2 | 1997 | 147 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2007 | 728 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2378 | 0.050 |
Why?
| | Light | 1 | 2005 | 403 | 0.050 |
Why?
| | Magnesium | 1 | 2003 | 156 | 0.050 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2022 | 58 | 0.050 |
Why?
| | Isradipine | 2 | 1995 | 3 | 0.050 |
Why?
| | Models, Structural | 3 | 1997 | 41 | 0.040 |
Why?
| | RNA, Messenger | 3 | 1998 | 2803 | 0.040 |
Why?
| | Allosteric Regulation | 1 | 2001 | 99 | 0.040 |
Why?
| | Restriction Mapping | 2 | 1999 | 81 | 0.040 |
Why?
| | Indicators and Reagents | 1 | 2001 | 106 | 0.040 |
Why?
| | CHO Cells | 1 | 2001 | 169 | 0.040 |
Why?
| | Lipid Bilayers | 1 | 2002 | 103 | 0.040 |
Why?
| | Cricetinae | 1 | 2001 | 305 | 0.040 |
Why?
| | Gestational Age | 2 | 2017 | 987 | 0.040 |
Why?
| | Amiloride | 2 | 1992 | 25 | 0.040 |
Why?
| | Spectrometry, Fluorescence | 1 | 2001 | 165 | 0.040 |
Why?
| | Cyclic GMP | 2 | 1978 | 90 | 0.040 |
Why?
| | Culture Techniques | 2 | 1991 | 66 | 0.040 |
Why?
| | Two-Hybrid System Techniques | 1 | 2000 | 59 | 0.040 |
Why?
| | Tetrodotoxin | 3 | 1990 | 40 | 0.040 |
Why?
| | Microscopy, Electron | 3 | 2012 | 414 | 0.040 |
Why?
| | Mammals | 1 | 2002 | 286 | 0.040 |
Why?
| | NAV1.6 Voltage-Gated Sodium Channel | 1 | 1999 | 11 | 0.040 |
Why?
| | Tetraethylammonium Compounds | 2 | 1990 | 8 | 0.040 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 2000 | 73 | 0.040 |
Why?
| | Protein Folding | 1 | 2001 | 276 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2002 | 500 | 0.040 |
Why?
| | Conserved Sequence | 2 | 1997 | 244 | 0.040 |
Why?
| | Peptides | 2 | 1996 | 998 | 0.040 |
Why?
| | Mice, Inbred Strains | 1 | 2000 | 396 | 0.040 |
Why?
| | Microscopy, Fluorescence | 1 | 2000 | 408 | 0.040 |
Why?
| | Heart Failure | 1 | 2012 | 2326 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2001 | 627 | 0.040 |
Why?
| | omega-Agatoxin IVA | 1 | 1998 | 1 | 0.040 |
Why?
| | Heart Rate | 1 | 2022 | 855 | 0.030 |
Why?
| | Spider Venoms | 1 | 1998 | 11 | 0.030 |
Why?
| | Microelectrodes | 2 | 2012 | 49 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 1998 | 254 | 0.030 |
Why?
| | Cell Compartmentation | 1 | 1998 | 52 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 1998 | 125 | 0.030 |
Why?
| | Gene Expression | 1 | 2003 | 1476 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2001 | 588 | 0.030 |
Why?
| | Shaker Superfamily of Potassium Channels | 1 | 1997 | 4 | 0.030 |
Why?
| | Mutagenesis, Insertional | 1 | 1997 | 67 | 0.030 |
Why?
| | Zebrafish | 1 | 2022 | 532 | 0.030 |
Why?
| | Electrochemistry | 1 | 1997 | 70 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 2001 | 573 | 0.030 |
Why?
| | Macromolecular Substances | 1 | 1997 | 216 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1997 | 362 | 0.030 |
Why?
| | Nimodipine | 1 | 1996 | 6 | 0.030 |
Why?
| | Leucine | 1 | 1997 | 116 | 0.030 |
Why?
| | Papillary Muscles | 1 | 1996 | 13 | 0.030 |
Why?
| | Peptide Fragments | 1 | 2000 | 693 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2017 | 204 | 0.030 |
Why?
| | Gap Junctions | 1 | 1997 | 67 | 0.030 |
Why?
| | Protein Transport | 1 | 2017 | 442 | 0.030 |
Why?
| | Blood | 1 | 1996 | 107 | 0.030 |
Why?
| | Molecular Structure | 1 | 1997 | 486 | 0.030 |
Why?
| | Snakes | 2 | 1986 | 19 | 0.030 |
Why?
| | Models, Molecular | 1 | 2000 | 1598 | 0.030 |
Why?
| | Cadmium Chloride | 1 | 1995 | 4 | 0.030 |
Why?
| | Barium Compounds | 1 | 1995 | 11 | 0.030 |
Why?
| | Lanthanum | 1 | 1995 | 13 | 0.030 |
Why?
| | Cadmium | 1 | 1995 | 68 | 0.030 |
Why?
| | omega-Conotoxin GVIA | 1 | 1994 | 5 | 0.030 |
Why?
| | Adenosine-5'-(N-ethylcarboxamide) | 1 | 1994 | 9 | 0.030 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1994 | 18 | 0.030 |
Why?
| | Cell Membrane Permeability | 1 | 1994 | 88 | 0.030 |
Why?
| | Reaction Time | 1 | 1996 | 433 | 0.030 |
Why?
| | Membranes | 1 | 1994 | 13 | 0.030 |
Why?
| | Phosphorylation | 1 | 1998 | 1707 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 1997 | 372 | 0.030 |
Why?
| | Egtazic Acid | 1 | 1994 | 37 | 0.030 |
Why?
| | Chlorides | 1 | 1995 | 138 | 0.030 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 1994 | 44 | 0.020 |
Why?
| | Swine | 1 | 1996 | 825 | 0.020 |
Why?
| | 3T3 Cells | 1 | 1993 | 156 | 0.020 |
Why?
| | Nicotinic Acids | 1 | 1992 | 5 | 0.020 |
Why?
| | Mathematics | 2 | 1983 | 101 | 0.020 |
Why?
| | Water Pollutants | 1 | 2012 | 20 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2012 | 116 | 0.020 |
Why?
| | Synapses | 2 | 1996 | 439 | 0.020 |
Why?
| | Cyprinidae | 1 | 2012 | 22 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2012 | 100 | 0.020 |
Why?
| | Organ Specificity | 1 | 1993 | 309 | 0.020 |
Why?
| | Executive Function | 1 | 2017 | 470 | 0.020 |
Why?
| | Male | 6 | 2017 | 72842 | 0.020 |
Why?
| | Child Development | 1 | 2017 | 483 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1991 | 157 | 0.020 |
Why?
| | Logistic Models | 1 | 2017 | 2134 | 0.020 |
Why?
| | Algorithms | 1 | 1999 | 1845 | 0.020 |
Why?
| | Body Temperature | 1 | 2012 | 227 | 0.020 |
Why?
| | Anesthetics | 1 | 2012 | 99 | 0.020 |
Why?
| | Tetraethylammonium | 1 | 1990 | 16 | 0.020 |
Why?
| | Cell Death | 1 | 1992 | 382 | 0.020 |
Why?
| | Peptides, Cyclic | 1 | 1992 | 273 | 0.020 |
Why?
| | 4-Aminopyridine | 1 | 1990 | 30 | 0.020 |
Why?
| | Phylogeny | 1 | 1993 | 917 | 0.020 |
Why?
| | beta-Galactosidase | 1 | 1989 | 76 | 0.020 |
Why?
| | Extremities | 1 | 1990 | 141 | 0.020 |
Why?
| | Tropomyosin | 1 | 1989 | 10 | 0.020 |
Why?
| | Freeze Fracturing | 2 | 2002 | 4 | 0.020 |
Why?
| | DNA Probes | 1 | 1989 | 59 | 0.020 |
Why?
| | Verapamil | 1 | 1989 | 37 | 0.020 |
Why?
| | Muscular Dystrophy, Animal | 1 | 1989 | 10 | 0.020 |
Why?
| | Embryonic and Fetal Development | 1 | 1989 | 93 | 0.020 |
Why?
| | Sarcolemma | 1 | 1989 | 35 | 0.020 |
Why?
| | Creatine Kinase | 1 | 1989 | 72 | 0.020 |
Why?
| | Base Sequence | 1 | 1992 | 2170 | 0.020 |
Why?
| | Nucleic Acid Hybridization | 1 | 1989 | 187 | 0.020 |
Why?
| | Necturus | 1 | 1988 | 14 | 0.020 |
Why?
| | Myosins | 1 | 1989 | 132 | 0.020 |
Why?
| | Genetic Markers | 1 | 1989 | 335 | 0.020 |
Why?
| | Stem Cell Transplantation | 1 | 1990 | 189 | 0.020 |
Why?
| | Female | 3 | 2017 | 78844 | 0.020 |
Why?
| | Dystrophin | 1 | 1988 | 41 | 0.020 |
Why?
| | Stereoisomerism | 1 | 1988 | 103 | 0.020 |
Why?
| | Genes | 1 | 1988 | 227 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2008 | 219 | 0.020 |
Why?
| | Motor Activity | 1 | 2012 | 718 | 0.020 |
Why?
| | Dimerization | 1 | 2008 | 189 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 1988 | 506 | 0.020 |
Why?
| | Brain | 2 | 1997 | 2947 | 0.020 |
Why?
| | Actins | 1 | 1989 | 425 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 1993 | 1454 | 0.010 |
Why?
| | Histological Techniques | 1 | 1986 | 39 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1986 | 335 | 0.010 |
Why?
| | Cations | 1 | 2005 | 83 | 0.010 |
Why?
| | Stem Cells | 1 | 1990 | 628 | 0.010 |
Why?
| | Biological Transport, Active | 1 | 1985 | 69 | 0.010 |
Why?
| | Tendons | 1 | 1986 | 131 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2017 | 6447 | 0.010 |
Why?
| | Quality of Life | 1 | 2017 | 3204 | 0.010 |
Why?
| | Prospective Studies | 1 | 2017 | 8057 | 0.010 |
Why?
| | Rubidium | 1 | 1983 | 11 | 0.010 |
Why?
| | Evoked Potentials | 1 | 1983 | 131 | 0.010 |
Why?
| | Cell Differentiation | 1 | 1989 | 2046 | 0.010 |
Why?
| | Kidney | 1 | 1989 | 1497 | 0.010 |
Why?
| | Liver | 1 | 1989 | 1896 | 0.010 |
Why?
| | Rana pipiens | 2 | 1978 | 20 | 0.010 |
Why?
| | Tumor Cells, Cultured | 2 | 1993 | 886 | 0.010 |
Why?
| | Pregnancy | 1 | 1992 | 7202 | 0.010 |
Why?
| | United States | 1 | 2017 | 16098 | 0.010 |
Why?
| | Thoracica | 1 | 1977 | 2 | 0.010 |
Why?
| | Potassium Chloride | 1 | 1977 | 40 | 0.010 |
Why?
| | Glutamates | 1 | 1977 | 66 | 0.010 |
Why?
| | Child | 1 | 2017 | 22707 | 0.010 |
Why?
| | Ethylamines | 1 | 1976 | 5 | 0.010 |
Why?
| | Organ Culture Techniques | 1 | 1996 | 154 | 0.010 |
Why?
| | Methylamines | 1 | 1976 | 39 | 0.010 |
Why?
| | Lidocaine | 1 | 1976 | 55 | 0.010 |
Why?
| | Gene Targeting | 1 | 1996 | 81 | 0.010 |
Why?
| | Ca(2+) Mg(2+)-ATPase | 1 | 1989 | 2 | 0.000 |
Why?
| | Calsequestrin | 1 | 1989 | 8 | 0.000 |
Why?
| | Calcium-Transporting ATPases | 1 | 1989 | 33 | 0.000 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1988 | 60 | 0.000 |
Why?
| | Molecular Weight | 1 | 1989 | 312 | 0.000 |
Why?
| | Pheochromocytoma | 1 | 1989 | 67 | 0.000 |
Why?
| | Cell Communication | 1 | 1989 | 328 | 0.000 |
Why?
| | Anura | 1 | 1978 | 43 | 0.000 |
Why?
| | Cyclic AMP | 1 | 1978 | 207 | 0.000 |
Why?
|
|
Beam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|